References 1970 - 1979

  • Gul S, Smith AD, Thompson RHS, et al. (1970) Fatty acid composition of phospholipids from platelets and erythrocytes in multiple sclerosis. J Neurol Neurosurg Psychiat 33, 506–510.
  • Swank RL (1970) Multiple sclerosis: twenty years on a low fat diet. Arch. Neurol. 23, 460–474.
  • Sinclair AJ & Crawford MA (1972) The accumulation of arachidonate and docosahexaenote in the developing rat brain. J. Neurochem 19, 1753–1758.
  • Millar JHD, Zilkha KJ, Langman MJS, Payling-Wright H, et al. (1973) Double-blind trial of linoleate supplementation of the diet in multiple sclerosis. Br Med J 1, 765–768.
  • Thompson RHS (1973) Fatty acid metabolism in multiple sclerosis. Biochemical Society Symposium 35, 103–111.
  • Alter M, Yamoor M & Harshe M (1974) Multiple sclerosis and nutrition. Arch. Neurol. 31, 267–272.
  • Agranoff BW & Goldberg D (1974) Diet and the geographical distribution of multiple sclerosis. Lancet, Nov 2 1061–1066.
  • Love WC, Cashell A, Reynolds M & Callaghan N (1974) Linoleate and fatty acid patterns of serum lipids in multiple sclerosis and other diseases. Br Med J 3, 18–21.
  • Thompson RHS (1975) Unsaturated fatty acids in multiple sclerosis. In Multiple Sclerosis Resaerch, pp. 184–193 [AN Davison, JH Humphrey, AL Liversedge, WI McDonald and JS Porterfield, editors]. USA, Elsevier: North Holland.
  • Wolfgram F (1975) Similar geographical distribution of multiple sclerosis and cancer of the colon. Acta. Neurol. Scandinav. 52, 294–302.
  • Shukla VKS & Clausen J (1978) Linoleate and fatty acid patterns of serum lipids in multiple sclerosis. Acta. Neurol. Scandinav 57, 270–274.
  • Tsang WM, Belin J, Monro JA, Smith AD, Thompson RHS & Zilkha KJ (1976) Relationship between plasma and lymphocyte linoleate in multiple sclerosis. J Neurol Neurosurg Psychiatry 39, 767–771.
  • Adda DH, BeraudE&DepiedsR(1977) Evidence for suppressor cells in Lewis rats’ experimental allergic encephalomyelitis. Eur J Immunol 7, 620–623.
  • Field EJ, Joyce G & Smith BM (1977) Erythrocyte-UFA (Eufa) mobility test for pathogenesis and handling of the disease. J Neurol 214, 113–127.
  • Heipertz R, Klauke W, Pilz H & Ritter G (1977) Serum fatty acids in multiple sclerosis. J. Neurology 214, 153–157.
  • Bates D, Fawcett PRW, Shaw DA & Weightman D (1978) Polyunsaturated fatty acids in the treatment of acute remitting multiple sclerosis. Br Med J. 2, 1390–1391.
  • Meade CJ, Mertin J, Sheena J & Hunt R (1978) Reduction by linoleic acid of the severity of experimental allergic encephalomyelitis in the guinea-pig. J Neuro Sci 35, 291–308.
  • Mertin J & Stackpoole A (1978) Suppression by essential fatty acids of experimental allergic encephalomyelitis is abolished by indomethacin. Prostaglandins and Medicine 1, 283–291.
  • Paty DW, Cousin HK, Read S & Adlakha K (1978) Linoleic acid in multiple sclerosis: failure to show any therapeutic benefit. Acta Neuro Scand 58, 53–58.

BMJ Millar 1973